V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20192482 | 20123971 | 1.9 | 57 | Palliative (P) | 2017-10-11 | 2017-10-11 | Docetaxel | 01 | N | DOCETAXEL | 101802473 |
| 20192483 | 20123972 | 1.76 | 54.5 | Palliative (P) | 2017-10-03 | 2017-10-31 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101305024 |
| 20192487 | 20123973 | 1.67 | 68.7 | null | 2017-12-15 | 2018-01-10 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100066760 |
| 20192488 | 20123974 | 1.52 | 60.1 | Palliative (P) | 2019-10-11 | 2019-10-12 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100258443 |
| 20192493 | 20123975 | 1.69 | 42.2 | Palliative (P) | 2018-06-19 | 2018-06-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101093543 |
| 20192495 | 20123976 | 1.63 | 61 | null | 2017-09-03 | 2017-09-03 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100178210 |
| 20192496 | 20123977 | 1.87 | 63 | null | 2019-05-25 | 2019-06-13 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101841530 |
| 20192507 | 20123978 | 1.84 | 68.9 | null | 2022-04-09 | 2022-04-23 | Docetaxel | 02 | null | DOCETAXEL | 101413312 |
| 20192514 | 20123979 | 1.63 | 56.9 | Palliative (P) | 2016-12-12 | 2016-12-21 | Docetaxel | N | null | DOCETAXEL | 101295762 |
| 20192515 | 20123980 | 1.61 | 73 | null | 2019-11-08 | 2019-11-19 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101578837 |
| 20192521 | 20123981 | 1.82 | 78.4 | null | 2017-12-04 | 2018-01-28 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100973113 |
| 20192522 | 20123982 | 1.63 | 85.2 | null | 2018-02-06 | 2018-03-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101745541 |
| 20192532 | 20123983 | 0 | 86.8 | Neo-adjuvant (N) | 2019-06-04 | 2019-06-04 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100229386 |
| 20192535 | 20123984 | 1.89 | 98 | null | 2017-09-22 | 2018-05-16 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100134438 |
| 20192537 | 20123985 | 1.74 | 88 | Palliative (P) | 2019-06-18 | 2019-07-02 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100100418 |
| 20192539 | 20123986 | 1.65 | 58.2 | Neo-adjuvant (N) | 2018-09-24 | 2018-09-25 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101335619 |
| 20192540 | 20123987 | 1.76 | 50.6 | Palliative (P) | 2022-02-27 | 2022-03-17 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100142237 |
| 20192543 | 20123988 | 1.86 | 71.8 | Palliative (P) | 2018-09-14 | 2018-10-04 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101615435 |
| 20192545 | 20123989 | 1.49 | 70 | null | 2017-02-08 | 2017-02-21 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CAPECITABINE + GEMCITABINE | 101108422 |
| 20192548 | 20123990 | 1.66 | 75.2 | null | 2018-03-14 | 2018-07-28 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101065271 |
| 20192549 | 20123991 | 1.53 | 78.35 | Palliative (P) | 2017-09-04 | 2017-09-18 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 101131035 |
| 20192553 | 20123992 | 1.3 | 61 | null | 2017-11-13 | 2019-12-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101719004 |
| 20192554 | 20123993 | 1.86 | 71.6 | null | 2019-05-29 | 2019-05-29 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101645758 |
| 20192557 | 20123994 | 1.91 | 53 | null | 2019-03-17 | 2019-03-23 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101306772 |
| 20192561 | 20123995 | 1.67 | 96.8 | null | 2021-03-29 | 2021-04-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | DOCETAXEL | 101412347 |
| 20192565 | 20123996 | 1.59 | 48 | Palliative (P) | 2017-04-07 | 2017-04-07 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101162741 |
| 20192568 | 20123997 | 0 | 53 | Palliative (P) | 2019-07-26 | 2019-07-28 | Docetaxel | 02 | N | DOCETAXEL | 101374196 |
| 20192571 | 20123998 | 1.59 | 101.55 | Palliative (P) | 2019-01-30 | 2019-05-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101027877 |
| 20192575 | 20123999 | 1.59 | 83.4 | Palliative (P) | 2019-07-27 | 2019-09-02 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101556007 |
| 20192582 | 20124000 | 1.69 | 68.7 | Adjuvant (A) | 2017-01-10 | 2017-01-10 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100310935 |
| 20192589 | 20124001 | 1.68 | 83.7 | null | 2019-08-16 | 2019-08-31 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101260716 |
| 20192592 | 20124002 | 1.68 | 100 | Palliative (P) | 2017-08-07 | 2017-08-08 | CAPECITABINE + GEMCITABINE | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101615073 |
| 20192602 | 20124003 | 1.59 | 68.6 | Palliative (P) | 2019-08-25 | 2019-08-25 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100969951 |
| 20192605 | 20124004 | 1.68 | 57.7 | Neo-adjuvant (N) | 2016-05-11 | 2016-05-11 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100522511 |
| 20192607 | 20124005 | 1.73 | 72.8 | Palliative (P) | 2020-03-03 | 2020-03-03 | Gemcitabine + Capecitabine | null | N | CAPECITABINE + GEMCITABINE | 101626403 |
| 20192609 | 20124006 | 1.74 | 81.4 | Palliative (P) | 2017-11-15 | 2017-12-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100469164 |
| 20192612 | 20124007 | null | 98 | null | 2019-01-30 | 2019-02-01 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100737624 |
| 20192621 | 20124008 | 1.76 | 68.7 | null | 2018-09-28 | 2018-10-02 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101802794 |
| 20192622 | 20124009 | 1.59 | 60.4 | Palliative (P) | 2016-03-13 | 2016-04-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101507382 |
| 20192624 | 20124010 | 1.8 | 78 | Palliative (P) | 2018-02-28 | 2018-09-04 | Docetaxel | 02 | N | DOCETAXEL | 100481224 |
| 20192626 | 20124011 | 1.7 | 114.7 | null | 2019-08-25 | 2019-09-09 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100933883 |
| 20192627 | 20124012 | 1.68 | 65 | null | 2018-07-30 | 2018-07-31 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101852073 |
| 20192628 | 20124013 | 1.53 | null | null | 2018-05-04 | 2018-07-19 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100296239 |
| 20192631 | 20124014 | 1.7 | 63.25 | Adjuvant (A) | 2016-01-17 | 2016-03-04 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100364776 |
| 20192632 | 20124015 | 1.59 | 62 | Palliative (P) | 2018-10-31 | 2018-10-31 | Docetaxel | 02 | N | DOCETAXEL | 101174982 |
| 20192634 | 20124016 | 1.7 | 108 | null | 2022-03-03 | 2022-03-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101751030 |
| 20192635 | 20124017 | 1.66 | 51.1 | Adjuvant (A) | 2017-01-29 | 2017-02-02 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101609531 |
| 20192636 | 20124018 | 1.7 | 73 | Palliative (P) | 2020-09-26 | 2022-01-18 | Docetaxel | 02 | N | DOCETAXEL | 101807690 |
| 20192639 | 20124019 | 1.46 | 113.5 | Palliative (P) | 2019-06-19 | 2019-06-19 | Docetaxel 75mg/m2 (21 day) | 02 | Y | DOCETAXEL | 101594735 |
| 20192640 | 20124020 | 1.76 | 73.2 | Palliative (P) | 2018-11-10 | 2019-04-23 | Docetaxel | 02 | N | DOCETAXEL | 100116139 |